Funds/Sectoral / Thematic/Bajaj Finserv Healthcare Fund

Bajaj Finserv Healthcare Fund

Bajaj Finserv Mutual Fund·Sectoral / Thematic·vs Nifty 500 TRI

The fund maintains a heavily concentrated pharma-centric positioning, with two-thirds of assets in pharmaceutical stocks and a top-10 cluster commanding nearly 60 percent of the portfolio. The addition of Senores Pharmaceuticals signals the manager is selectively hunting for undervalued or emerging plays within the sector, while the reduced cash position suggests conviction in pharmaceutical valuations despite near-term market pressures. This remains a pure-play bet on India's drug manufacturing resilience and domestic healthcare demand, with minimal diversification cushion.

Portfolio analysis · April 2026

NAV & Returns

Plan	NAV	1M	3M	6M	1Y	3Y CAGR	5Y CAGR
Regular Growth	₹10.2370	+9.49%	+8.77%	+2.73%	+10.85%	—	—

Returns above 1Y are CAGR. Direct plan rows highlighted. NAV from AMFI.

Portfolio Metrics(latest month)

Holdings

Top 5 Weight

37.40%

Top 10 Weight

59.13%

Active Share

—

Large Cap

35.24%

Gini

0.395

What Changed2026-03-31 → 2026-04-30

Holdings: 35 → 36+1 added−0 removed19 weight shifts ≥ 0.1%

Stock	Sector	Weight
Senores Pharmaceuticals Limited	Pharmaceuticals & Biotechnology	0.84%

Full Holdings

#	Holding	Sector	Class	% to NAV
1	Divi's Laboratories Limited INE361B01024	Pharmaceuticals & Biotechnology	EQUITY	9.10%
2	Sun Pharmaceutical Industries Limited INE044A01036	Pharmaceuticals & Biotechnology	EQUITY	9.00%
3	Aurobindo Pharma Limited INE406A01037	Pharmaceuticals & Biotechnology	EQUITY	6.57%
4	Apollo Hospitals Enterprise Limited INE437A01024	Healthcare Services	EQUITY	6.46%
5	Piramal Pharma Limited INE0DK501011	Pharmaceuticals & Biotechnology	EQUITY	6.27%
6	Torrent Pharmaceuticals Limited INE685A01028	Pharmaceuticals & Biotechnology	EQUITY	5.13%
7	Rubicon Research Limited INE506V01022	Pharmaceuticals & Biotechnology	EQUITY	4.48%
8	Emcure Pharmaceuticals Limited INE168P01015	Pharmaceuticals & Biotechnology	EQUITY	4.26%
9	Neuland Laboratories Limited INE794A01010	Pharmaceuticals & Biotechnology	EQUITY	3.96%
10	Max Healthcare Institute Limited INE027H01010	Healthcare Services	EQUITY	3.90%
11	Fortis Healthcare Limited INE061F01013	Healthcare Services	EQUITY	3.43%
12	Zydus Wellness Limited INE768C01028	Food Products	EQUITY	2.73%
13	IPCA Laboratories Limited INE571A01038	Pharmaceuticals & Biotechnology	EQUITY	2.39%
14	Vijaya Diagnostic Centre Limited INE043W01024	Healthcare Services	EQUITY	2.16%
15	Navin Fluorine International Limited INE048G01026	Chemicals & Petrochemicals	EQUITY	2.11%
16	Glenmark Pharmaceuticals Limited INE935A01035	Pharmaceuticals & Biotechnology	EQUITY	2.07%
17	Sanofi Consumer Healthcare India Limited INE0UOS01011	Pharmaceuticals & Biotechnology	EQUITY	2.04%
18	Shaily Engineering Plastics Limited INE151G01028	Consumer Durables	EQUITY	1.94%
19	GlaxoSmithKline Pharmaceuticals Limited INE159A01016	Pharmaceuticals & Biotechnology	EQUITY	1.72%
20	Laurus Labs Limited INE947Q01028	Pharmaceuticals & Biotechnology	EQUITY	1.70%

Sector Allocation

Pharmaceuticals & Biotechnology66.5%

Healthcare Services18.5%

nan3.3%

Food Products2.7%

Personal Products2.5%

Chemicals & Petrochemicals2.1%

Consumer Durables1.9%

Retailing1.4%

Insurance1.1%

Top 10 sectors by % to NAV. Excludes derivatives.